These data indicate that CD38+CD39+CD25-CD4+ TILs not only express granzymes and perforin, but can also recognize tumor antigen in an MHC class II-dependent manner and are functionally capable of lysing tumor cells. This evidence concerns the gene CD4 and neoplasm.